The protease-resistant prion protein (PrPres) of a few natural scrapie isolates identified in sheep, reminiscent of the experimental isolate CH1641 derived from a British natural scrapie case, showed partial molecular similarities to ovine bovine spongiform encephalopathy (BSE). Recent discovery of an atypical form of BSE in cattle, L-type BSE or BASE, suggests that also this form of BSE might have been transmitted to sheep. We studied by Western blot the molecular features of PrPres in four “CH1641-like” natural scrapie isolates after transmission in an ovine transgenic model (TgOvPrP4), to see if “CH1641-like” isolates might be linked to L-type BSE. We found less diglycosylated PrPres than in classical BSE, but similar glycoform proportions and apparent molecular masses of the usual PrPres form (PrPres #1) to L-type BSE. However, the “CH1641-like” isolates differed from both L-type and classical BSE by an abundant, C-terminally cleaved PrPres product (PrPres #2) specifically recognised by a C-terminal antibody (SAF84). Differential immunoprecipitation of PrPres #1 and PrPres #2 resulted in enrichment in PrPres #2, and demonstrated the presence of mono- and diglycosylated PrPres products. PrPres #2 could not be obtained from several experimental scrapie sources (SSBP1, 79A, Chandler, C506M3) in TgOvPrP4 mice, but was identified in the 87V scrapie strain and, in lower and variable proportions, in 5 of 5 natural scrapie isolates with different molecular features to CH1641. PrPres #2 identification provides an additional method for the molecular discrimination of prion strains, and demonstrates differences between “CH1641-like” ovine scrapie and bovine L-type BSE transmitted in an ovine transgenic mouse model.
The origin of the transmissible agent involved in the food-borne epidemic of bovine spongiform encephalopathy (BSE) remains a mystery. It has recently been proposed that this could have been the result of the recycling of an atypical, more probably sporadic, form of BSE (called bovine amyloidotic spongiform encephalopathy, or L-type BSE) in an intermediate host, such as sheep. In this study we analyzed the molecular features of the disease-associated protease-resistant prion protein (PrPres) found in the brain of transgenic mice overexpressing the ovine prion protein after experimental infection with prions from bovine classical and L-type BSEs or from ovine scrapie. Scrapie cases included rare “CH1641-like” isolates, which share some PrPres molecular features with classical BSE and L-type BSE. Scrapie isolates induced in transgenic mouse brains the production of a C-terminally cleaved form of PrPres, which was particularly abundant from “CH1641-like” cases. In contrast, this C-terminal prion protein product was undetectable in ovine transgenic mice infected with bovine prions from both classical and L-type BSE. These findings add a novel approach for the discrimination of prions that may help to understand their possible changes during cross-species transmissions.
Citation: Baron T, Bencsik A, Vulin J, Biacabe A-G, Morignat E, Verchere J, et al. (2008) A C-Terminal Protease-Resistant Prion Fragment Distinguishes Ovine “CH1641-Like” Scrapie from Bovine Classical and L-Type BSE in Ovine Transgenic Mice. PLoS Pathog 4(8): e1000137. https://doi.org/10.1371/journal.ppat.1000137
Editor: Neil Mabbott, University of Edinburgh, United Kingdom
Received: April 14, 2008; Accepted: July 31, 2008; Published: August 29, 2008
Copyright: © 2008 Baron et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partly supported by grants from the Neuroprion European network of Excellence (FOOD-CT-2004-506579 EUROSTRAINS project) and GIS "Infections à prions."
Competing interests: The authors have declared that no competing interests exist.
Prion diseases such as Creutzfeldt-Jakob disease (CJD) in humans, scrapie in sheep and goats and bovine spongiform encephalopathy (BSE) in cattle are tightly associated with the accumulation of an abnormal form of a host-encoded cellular prion protein (PrP C) in infected tissues . The biochemical properties of this disease-associated form of the protein (PrPd), which include insolubility in non-denaturing detergents and partial resistance to degradation by proteases, differ from those of the normal form. Whereas the normal protein is fully sensitive to proteases, the abnormal prion protein is only partly degraded (PrPres) due to removal of the amino-terminal end. In most cases, a large protease-resistant C-terminal core fragment is identified which has a gel mobility of ∼19–21 kDa in its unglycosylated form. However, in some prion diseases, such as some cases of human Creutzfeldt-Jakob disease  or the H-type atypical form of BSE , a much smaller C-terminal PrPres product has also been reported.
A typical molecular signature of the BSE agent has been identified by PrPres Western blot analysis, which allows such methods to be used to identify the possible presence of BSE in sheep or goats –. The origin of the BSE agent in cattle is still unknown, and its possible reservoir has not yet been identified. A few isolates of TSEs were described in sheep that showed partial similarities with experimental ovine BSE, with a lower molecular mass of unglycosylated PrPres than in most scrapie cases, as found in ovine BSE. However the very high proportions of diglycosylated PrPres found in ovine BSE were not generally apparent in such isolates. This was first demonstrated in the CH1641 experimental scrapie isolate ,, then in a few natural scrapie cases in Great Britain and France ,. Bioassays performed in wild-type mice to identify prion strains from TSE isolates were reported to identify the biological signature of the BSE agent –, but the CH1641 source failed to transmit the disease to such mice ,. Both CH1641 and “CH1641-like” natural isolates were however transmitted in an ovine transgenic mouse model (TgOvPrP4), showing similar PrPres molecular features in both transgenic mice and sheep, i.e. a low apparent molecular of unglycosyslated PrPres (referred as l-type PrPres) ,. In some of the cases this could be not the unique molecular phenotype identified in all scrapie-infected mice, with some of the mice also showing PrPres with a higher apparent molecular mass (h-type PrPres) .
Deviant phenotypes of BSE have recently been reported in cattle however (H and L-types, based on the PrPres features in cattle brain) –. Bioassays in wild-type and transgenic mice showed that these were consistent with the presence of two distinct strains, both differing from the single classical BSE strain involved in the food-borne BSE epidemic , –. Thus, the possible transmission of such forms of BSE in other species such as small ruminants also needs to be considered. Recently the hypothesis has been raised that the classical BSE epidemic might have originated from the recycling of one of these atypical forms of BSE (L-type BSE) after a first cross-species transmission, possibly in sheep ,. Recent studies of a transmissible mink encephalopathy (TME) isolate in TgOvPrP4 mice also showed similar phenotypic features to those of L-type BSE, suggesting a possible cross-species transmission of L-type BSE by oral route . Given their unusual molecular properties, “CH1641-like” or CH1641 isolates might be the result of a transmission of L-type BSE to sheep or might represent similar isolates occurring in sheep.
In this study we compared the PrPres molecular features of a series of natural “CH1641-like” and experimental CH1641 scrapie isolates, with those of classical and L-type BSE, after transmission to TgOvPrP4 ovine transgenic mice. We demonstrated the abundance of a C-terminal PrPres fragment (PrPres #2), which distinguished these ovine scrapie isolates from both bovine classical and L-type BSEs after transmission in a common ovine trangenic mouse model.
“CH1641-like” isolates and L-type BSE share similar Western blot features to the usual PrPres form (PrPres #1) in TgOvPrP4 mice
We compared the PrPres Western blot profiles, after transmission in TgOvPrP4 ovine transgenic mice, of two recently identified natural sheep TSE isolates (05-825 and 06-017) that showed PrPres molecular features comparable to the experimental CH1641 scrapie isolate, i.e., a low apparent molecular mass (l-type) close to that found in ovine BSE. When the Bar233 antibody was used to detect the usual form of PrPres (PrPres #1), the molecular features, i.e. the apparent molecular masses of the three PrPres glycoforms and the glycoforms proportions, were similar in all PrPres positive mice in both experimental groups (Figure 1A). The glycoform proportions in each of the natural 4 “CH1641-like” isolates (or in CH1641) were significantly different from those of classical BSE (p<0.0001 for all 15 tests), with essentially lower levels of diglycosylated PrPres than in classical BSE (Figures 1A and 2A). Lane by lane comparisons revealed a slightly lower apparent molecular mass of unglycosylated PrPres in mice infected with scrapie rather than ovine BSE, and also after PNGase deglycosylation (Figure 1B). Nevertheless, these differences (0–0.3 kDa) remained within the range of the possible variations of an individual sample in a given Western blot experiment. These molecular features were similar to those found in TgOvPrP4 mice infected with two other previously described “CH1641-like” natural scrapie isolates, at first or second passages (Figure 1C and 1D), in all (TR316211 isolate) or in some (O104 isolate) of the mice .
CH1641 and natural “CH1641-like” (06-017, 05-825, TR316211, and O104) scrapie isolates are compared with experimental ovine BSE (Ov BSE), L-type (L-BSE), or classical (C-BSE) BSE in cattle. (A) and (B) show results in TgOvPrP4 mice at first passage and (C) and (D) at second passage. PrPres was analysed before ([A] and [C]) or after ([B] and [D]) PNGase deglycosylation.
Glycoform ratios of PrPres in individual mice inoculated with ovine or bovine isolates (first passage) are shown in (A) and (B), respectively. In (A), CH1641 is shown in red, and natural isolates 06-017 and 05-0825 in blue. In (B), Classical and L-type BSE are shown in red and green, respectively. PrPres was detected by Bar233 antibody.
In contrast, the PrPres #1 molecular features in TgOvPrP4 mice infected with “CH1641-like” isolates did not differ from those found in mice infected with L-type BSE. The low apparent molecular mass of unglycosylated PrPres was similar to that found in mice infected with classical BSE (Figure 1C), and also after PNGase deglycosylation (Figure 1D). Glycoform proportions did not differ significantly between any of the natural “CH1641-like” isolates (or CH1641) and L-type BSE with all cases showing lower levels of diglycosylated PrPres than in classical BSE (Figures 1C and 2B) (p>0.30 for all tests except the one comparing the monoglycosylated PrPres band in TR316211-infected mice for which p = 0.07).
Low apparent molecular masses of PrPres were consistently associated with strongly reduced labeling by P4 monoclonal antibody (data not shown).
A C-terminal PrPres fragment (PrPres #2) is detected in ovine transgenic mice infected with scrapie isolates but not with L-type or classical BSE
We then used SAF84 for PrPres detection, that identified an additional band at ∼14 kDa (PrPres #2) in TgOvPrP4 mice infected with the four natural “CH1641-like” isolates and with the experimental CH1641 isolate (Figure 3A and 3C). This was associated with lighter, more diffuse labeling below the well defined ∼19 kDa unglycosylated PrPres #1 band, consistent with the presence of a monoglycosylated form derived from the ∼14 kDa PrPres product. This PrPres #2 fragment was not detected in mice infected with classical BSE transmitted to sheep or with L-type BSE in cattle (Figure 3A and 3C). The existence of two distinct PrPres fragments of ∼19 and ∼14 kDa detected with SAF84 antibody only in the “CH1641-like” isolates was also demonstrated after deglycosylation by PNGase treatment (Figure 3B and 3D). Comparison of PrPres profiles between TgOvPrP4 mice and sheep or cattle (Figure S1) indicate that TgOvPrP4 faithfully reproduced PrPres features of ruminants following transmission of scrapie or BSE, including regarding the presence of PrPres #2 in “CH1641-like” scrapie but not in BSE.
CH1641 and natural “CH1641-like” (06-017, 05-825, TR316211, and O104) scrapie isolates are compared with ovine BSE (Ov BSE), L-type (L-BSE), or classical (C-BSE) natural BSE in cattle and transmissible mink encephalopathy experimentally transmitted to cattle (TME bov) . (A) and (B) show results in TgOvPrP4 mice at first passage and (C) and (D) at second passage. PrPres was analysed before ([A] and [C]) or after ([B] and [D]) PNGase deglycosylation.
The ∼14 kDa band was not detected in TgOvPrP4 mice that had been infected with an isolate from cattle experimentally infected with transmissible mink encephalopathy (TME) (Figure 3), previously demonstrated to have phenotypic features similar to L-type BSE in TgOvPrP4 mice (PrPres of low apparent molecular mass) .
We analyzed PrPres in TgOvPrP4 mice infected from six different BSE sources including (i) 3 natural isolates from cattle, goat, and a cheetah with feline spongiform encephalopathy (FSE) and (ii) 3 experimental sources from sheep (homozygous either for A136R154Q71 or A136R154R171 prnp allele) or from C57Bl/6 wild-type mice. All these BSE sources showed a similar PrPres profile with low apparent molecular mass (∼19 kDa), close to that found in CH1641-infected mice, but with higher levels of diglycosylated PrPres, after the use of both Bar233 and SAF84 antibodies (Figures 4A, 4B, and 6). In contrast to the CH1641 source, none of them showed detectable levels of the ∼14 kDa PrPres fragment with SAF84 antibody, even after PNGase deglycosylation (Figure 4B and 4C).
BSE sources shown in (A–C) include BSE from cattle (lane 2), sheep homozygous for the A136R154Q171 (lane 3) or A136R154R171 (lane 4) prnp allele, goat (lane 5), and cheetah (lane 6). “Non-CH1641-like” natural scrapie isolates include O171, O59, O69, O87, and O111 scrapie isolates. PrPres in TgOvPrP4 mice (first passage) was analysed before ([A,B,D,E]) or after ([C] and [F]) PNGase deglycosylation. PrPres was detected by Bar233 antibody in (A) and (D) and by SAF 84 antibody in (B), (C), (E), and (F).
However, a ∼14 kDa band was also detected in mice infected with 5 natural scrapie isolates (Figure 4E), otherwise characterized by a higher apparent molecular mass of PrPres #1 compared to CH1641 (Figure 4D) or to ovine BSE, although this ∼14 kDa band was clearly less intense than from “CH1641-like” isolates.
The C-terminal PrPres fragment (PrPres #2) is preferentially associated with PrPres of low apparent molecular mass
We then evaluated the presence of the C-terminally cleaved PrPres fragment detected by SAF84 antibody in the experimental sources that had been adapted to TgOvPrP4 mice. (1) Among the two experimental scrapie isolates, unlike CH1641, this PrPres fragment was not detected from the SSBP/1 isolate (Figure 5). (2) From experimental strains derived from mouse-adapted scrapie or BSE strains, it was only detected in the 87V strain of scrapie which is also characterized by a low apparent molecular mass of the unglycosylated PrPres #1 form, similar to that found in BSE, but not in the three other scrapie strains (C506M3, Chandler and 79A) otherwise characterized by a high molecular mass of unglycosylated PrPres (Figure 5).
Scrapie sources include SSBP1 and CH1641 experimental scrapie isolates and Chandler, 87V, 79A, and C506M3 scrapie strains in TgOvPrP4 mice (second passage). BSE is derived from C57Bl/6 mice infected with classical BSE (Mu BSE) (second passage in TgOvPrP4 mice). PrPres was analysed before (A, B) or after (C) PNGase deglycosylation and detected using Bar233 (A) or SAF84 (B, C).
In mice infected with natural scrapie isolates and CH641, the respective proportions of the ∼14 and ∼19 kDa bands, as observed after PNGase deglycosylation, were quantified and the ratios of PrPres #2/PrPres #1 determined (Figure 6). The mean proportions of PrPres #2 in the “CH1641-like” isolates (3–5 mice analysed per experimental group) represented 22.7% to 39.3% of the total signal, except for the O104 isolate for which these proportions were smaller (12.4%–20%) in 4 of the 5 mice analysed. The proportions of PrPres #2 in mice infected with the other scrapie isolates (“non CH1641-like”) (1–3 mice analysed per experimental group), were below 10% in most mice, except those infected with O111 (15.9%–19.4%). Statistical analyses of the data confirmed the significantly higher proportions of PrPres #2 in mice infected with “CH1641-like” isolates (or CH1641) compared with other scrapie isolates (p<0.0001), as well as the significantly higher proportions of PrPres #2 in the O111 isolate within the “non CH1641-like” isolates (p = 0.02). No significant differences in these proportions of PrPres #2 were found between the natural “CH1641-like” isolates and the experimental CH1641 isolate (p = 0.42).
Proportions of PrPres #2 were evaluated by repeated Western blot analyses of the samples after PNGase deglycosylation and detection using SAF84 antibody. In the case of O104-infected mice, the mice are numbered as indicated in Figure 7 showing Western blot results.
Transmission studies of the O104 isolate showed the presence of a mixture of two distinct PrPres phenotypes, with either high (h-type) or low (l-type) apparent molecular masses of unglycosylated PrPres, in variable proportions in each individual mouse, as shown using Bar233 detection after PNGase treatment (Figure 7A) . The l-type PrPres, compared to the h-type, is only faintly labeled by the P4 antibody, but a P4-labelled PrPres sub-population that migrates similarly to the h-type PrPres can be identified in mice with l-type PrPres (Figure 7B). When the SAF84 antibody was used (Figure 7C), the C-terminal PrPres fragment was detected in all the O104 infected mice, but the lowest proportion (12.4%) (Figure 6) was found in the sole mouse that showed the most important proportions of h-type PrPres (lanes 4 in Figure 7). These data are also consistent with a preferential association of PrPres #2 with PrPres #1 of low apparent molecular mass (l-type) in this scrapie isolate.
PrPres was analysed in TgOvPrP4 mice (first passage) by Western blot after PNGase deglycosylation and detected using Bar233, P4, and SAF84 monoclonal antibodies in (A), (B), and (C), respectively. PrPres from individual mice infected with O104 isolate (first passage) is shown, with BSE derived from BSE-infected C57Bl/6 mice (Mu BSE) and C506M3 scrapie controls in TgOvPrP4 mice (second passage). O104-infected mice are numbered as indicated in Figure 5 showing the proportions of PrPres #2.
Differential immunoprecipitation shows PrPres #2 as a glycosylated PrPres fragment
Immunoprecipitation experiments were carried out to enrich the PrPres #2 form in the samples and characterize it. Successive rounds of immunoprecipitation on magnetic beads coated with Sha31 N-terminal antibody that only recognizes PrPres #1, allowed progressive depletion of the PrPres #1 in the samples (Figure 8). After 7 rounds of immunoprecipitation, PrPres #1 becomes only barely detectable. Immunoprecipitation was then performed using the C-terminal SAF84 antibody that recognizes both PrPres #1 and PrPres #2. Three bands were detected at ∼22, 18, and 14 kDa, showing that PrPres #2, previously identified as an unglycosylated ∼14 kDa band, is also isolated from the mouse brains in monoglycosylated and diglycosylated forms.
Western blot analysis of PrPres from TgOvPrP4 infected with a “CH1641-like” isolate (TR316211). PrPres released from beads after each capture cycle is shown for 5 successive cycles using Sha31-coated beads (lanes 3 to 7, respectively), then from the following capture cycle using SAF84-coated beads (lane 8). PrPres controls from C506M3 strain and TR316211 are shown on lanes 1 and 2, respectively. PrPres was detected using SAF84 antibody that recognizes both PrPres #1 and PrPres #2 forms.
The presence of this three band PrPres #2 form was confirmed by differential immunoprecipitation in CH1641, “CH1641-like” isolates, and 87V but also in the O111 “non-CH1641-like” scrapie isolate. It could not be detected in mice infected with ovine BSE, L-type BSE or cattle experimentally infected with transmissible mink encephalopathy.
Neuropathological investigations of “CH1641-like” isolates in TgOvPrP4 mice
The neuropathological analyses of the first passage experiments indicated comparable distribution of disease-associated prion protein in the brain of the transgenic mice among the “CH1641-like” sheep scrapie group (Figure S2). This was particularly clear for the 05-825 and 06-017 isolates that resulted in similar intensity of pathological PrP accumulation (Figure S2C and S2D). Overall, these data were also not dissimilar from those already described for the first passage of L-type BSE . In both “CH1641-like” scrapie and L-type BSE, the florid plaque type of PrPsc deposition reported in this transgenic mouse line infected with classical BSE was never observed. However it is possible to underline some clear distinctive features such as a difference in the cortex targeting that was less intense compared to L-type BSE, even in the most severely affected cases (05-825 and 06-017 isolates) (Figure S2E). Remarkably the types of PrPd deposition were also different; in the “CH1641-like” sheep scrapie group the deposition of pathological PrP was fine granular compared to L-type BSE in which plaque-like deposition were sometimes noticeable. Also, in the mesencephalon (raphe dorsalis), the deposition was intraneuronal for the “CH1641-like” sheep scrapie group but not in the brain of mice infected with L-type BSE. These data thus indicate some differences in the biological features of “CH1641-like” isolates, not only with classical BSE, but also with L-type BSE.
This study describes the molecular analyses of PrPres after transmission into TgOvPrP4 ovine transgenic mice from 4 natural ovine scrapie isolates whose PrPres features in sheep were similar to those previously described for the experimental CH1641 scrapie isolate . Two of these previously unreported isolates (05-825 and 06-017) behaved as previously described for CH1641 and another natural isolate (TR316211) during the first passage in TgOvPrP4 mice, showing low molecular mass PrPres (l-type PrPres) in all mice ,. In contrast, all the TgOvPrP4 mice receiving 5 natural scrapie isolates characterized by high PrPres molecular masses (h-type PrPres) in the sheep brain, showed PrPres of high molecular mass. Detailed analyses showed, as previously described in the CH1641 isolate in sheep  and in TgOvPrP4 mice , a slightly lower PrPres molecular mass in TgOvPrP4 mice from the “CH1641-like” isolates than from ovine BSE, although the resolution of small gels made discrimination difficult. Our results are quite consistent with previous studies of the CH1641 isolate by the immunohistochemical “peptide mapping” method, which revealed that PrPd in the CH1641 isolate was truncated further upstream in the N terminus than from experimental BSE . The biochemical PrPres features of these scrapie isolates differ from BSE mainly in their moderately high proportions of di-glycosylated PrPres (50%–60%), whereas ovine BSE is characterized by higher proportions of di-glycosylated PrPres ,,. Molecular discrimination of strains based on the relative proportions of glycoforms is however less reliable than that of PrPres molecular masses, given the large measurement variations and poor standardization of analytical methods , , –. Furthermore glycoforms proportions of BSE in sheep have only been determined from a very limited number of sources. A recent study of classical BSE in cattle showed large individual variations (∼20%) in the proportions of di-glycosylated PrPres .
The question of a possible transmission of BSE in small ruminants now needs to be re-examined considering the recent identification of atypical cases of BSE (H-type or L-type) in cattle –. Recent studies have indeed hypothesized that cross-species transmission of such rare atypical cases could be at the origin of the BSE epidemic in cattle ,,. The first experimental support for this hypothesis was obtained following the discovery of a BSE-like phenotype in mice following transmission of L-type BSE in wild-type mice (C57Bl, SJL)  or in an ovine transgenic (tg338) mouse line . However, unlike tg338, which expressed 8- to 10-fold levels of V136 R154 Q171 ovine PrP, the phenotype of the L-type BSE remained distinct from classical BSE during at least two passages in TgOvPrP4 mice that expressed 2- to 4-fold levels of the A136 R154 Q171 ovine PrP . It is noteworthy that, in cattle, the essential difference between L-type BSE and classical BSE is the slightly lower apparent molecular mass and the lower proportions of diglycosylated PrPres –, reminiscent of the differences between CH1641 and classical BSE experimentally transmitted to sheep ,,. The phenotypic features of L-type BSE have not yet been reported in sheep. In this study we showed that the PrPres molecular masses and glycoform proportions between “CH1641-like” scrapie isolates and L-type BSE transmitted into TgOvPrP4 mice were indistinguishable, in addition to survival periods in the same range at second passage.
However our study revealed that a highly sensitive C-terminal antibody (SAF84) recognised an abundant PrPres product (PrPres #2) in TgOvPrP4 mice infected with “CH1641-like” isolates, the unglycosylated form of which migrates at ∼14 kDa, in addition to the usual PrPres product (PrPres #1) which migrates at ∼19 kDa in its unglycosylated form. The presence of mono- and di-glycosylated forms derived from this PrPres cleavage product was confirmed by differential immunoprecipitation of PrPres #1 and PrPres #2. Depletion of PrPres #1 using N-terminal antibodies allowed the samples to be enriched in C-terminally cleaved PrPres #2, which then appeared in a 3-band pattern between 14 and 22 kDa. Such experiments also confirm that PrPres #2 is only faintly recognized by Sha 31 antibody, which recognizes the 148–155 region of the ovine PrP protein, suggesting that this region is absent from most of the PrPres #2 fragments. PNGase deglycosylation also facilitated the identification of PrPres #2, and permitted quantification of the respective proportions of PrPres #2 and PrPres #1. Whereas PrPres #2 was abundant in TgOvPrP4 mice infected with “CH1641-like” isolates, lower levels of PrPres #2 could also be detected from 5 natural isolates with h-type PrPres transmitted into TgOvPrP4 mice. C-terminally cleaved PrPres products have previously been described in sporadic or genetic Creutzfeldt-Jakob disease in humans . Although the presence of low levels of PrPres #2 in BSE and L-type BSE cannot be fully excluded, this PrPres form remained undetected in our experiments with these BSE forms, even after differential immunoprecipitation. This was also the case in classical BSE transmitted in a variety of different species. Interestingly, similar results were obtained in TgOvPrP4 mice infected with an isolate from cattle experimentally infected with transmissible mink encephalopathy (TME), consistent with previous studies showing similarities with L-type BSE . Our results thus reinforce the molecular discrimination of “CH1641-like” scrapie isolates from classical BSE, but also indicate a clear molecular difference with L-type BSE transmitted from cattle to ovine transgenic mice. However, further comparisons including those of biological and histopathological features during serial passages in this mouse model will be required, as well as transmission studies performed from L-type BSE experimentally transmitted to sheep.
We have also recently described the identification of a C-terminally cleaved PrPres #2 form in H-type BSE, in cattle and after transmission to C57Bl/6 mice . However, a relationship between “CH1641-like” scrapie isolates and H-type BSE seems unlikely. H-type BSE is indeed characterized by a high PrPres molecular mass comparable to most natural scrapie cases, in contrast to the low PrPres molecular mass, which is the hallmark of “CH1641-like” isolates. Although the transmission of H-type BSE in sheep has not yet been reported, a high PrPres molecular mass was maintained upon transmission in tg338 ovine transgenic mice . Unfortunately, direct comparisons with H-type BSE in TgOvPrP4 mice were not possible since we were unable to transmit the disease from several cattle H-type isolates to these mice, at least at first passage . As these same H-type isolates were transmitted in tg338 expressing higher levels of the V136 R154 Q171 ovine PrP protein , this could suggest a high species and/or strain barrier for H-type BSE in sheep. Conversely, both classical and L-type BSEs were readily transmitted in TgOvPrP4 mice ,.
The presence of PrPres #2 within the different scrapie sources, was preferentially associated with PrPres #1 of low molecular mass. When several experimental scrapie sources were analysed, PrPres #2 was only detected in the 87V strain, characterized by l-type PrPres, but not in C506M3, Chandler or 79A strains or in the SSBP/1 isolate with h-type PrPres, still emphasizing the need of further comparisons between 87V and “CH1641-like” isolates . Although PrPres #2 could also be detected after the transmission of natural scrapie isolates with high molecular mass, the levels were consistently lower than in “CH1641-like” isolates. It might be that the presence of low levels of PrPres #2 in scrapie isolates with h-type PrPres indicates a mixture of PrPres phenotypes in these scrapie sources, with the levels of l-type PrPres undetectable. This possibility should be considered in the light of certain observations. (1) A scrapie case with both h-type and l-type PrPres has recently been described in the UK, each PrPres phenotype originating from two different brain areas . (2) Our recent transmission studies of two “CH1641-like” isolates (O100 and O104) from the same flock into TgOvPrP4 showed the presence of h-type PrPres in some of the mice suggesting a possible mixture of the two PrPres phenotypes in the initial ovine scrapie isolates; these two PrPres phenotypes might be selected, at least in part, during the second passage in TgOvPrP4 mice . Studies of the initial ovine brain samples by immunohistochemistry indeed revealed the presence of differently cleaved PrPres forms in different brain nuclei . (3) Transmission of scrapie in cattle from a brain pool (British source) with h-type PrPres produced two cows with l-typePrPres . h-type PrPres was detected in a second brain sample from one of the two animals. (4) Similar results were observed in a bovine transgenic mouse line, the mobility in mice being faster than in the original scrapie isolate (Irish source) . All together, these data suggest that l-type PrPres could be present in a number of scrapie sources. The identification of “CH1641-like” isolates might be the fortuitous and rare result of analysing samples in which the l-type PrPres of low molecular mass is more abundant.
Further characterization of the biological properties of scrapie sources with l-type PrPres will be required firstly to establish whether these correspond to a single strain of infectious agent or involve a variety of distinct scrapie strains, and secondly to better understand the characteristics of their transmission.
Materials and Methods
The TSE sheep isolates (Table 1) included the experimental CH1641 scrapie isolate (kindly provided by N. Hunter, Institute for Animal Health, Edinburgh) and four natural French “CH1641-like” TSE isolates. Transmission studies and initial data concerning the molecular analyses of CH1641 and of two natural “CH1641-like” isolates (O104, TR316211) transmitted to TgOvPrP4 ovine transgenic mice, have already been described ,. Two other field isolates from A136 R154 Q171 homozygous sheep (05-825 and 06-017) were now included, that showed a low apparent molecular mass of unglycosylated PrPres (0.1–0.4 kDa lower than in cattle BSE), as also described in experimental ovine BSE and reduced PrPres labelling with P4 monoclonal antibody in comparison to most natural scrapie cases that show PrPres of higher molecular mass.
Other TSE sources examined in TgOvPrP4 mice included (i) 5 natural scrapie isolates identified by clinical surveillance in France, with PrPres of high apparent molecular mass (“non-CH1641-like”) (Table 1); (ii) the SSBP/1 experimental scrapie isolate ; (iii) experimental scrapie strains, derived from mouse-adapted strains, C506M3, Chandler, 79A, 87V ,; (iv) BSE from cattle or obtained after natural transmission (goat, cheetah) ,, or experimental transmission (sheep homozygous for the A136R154Q171 or A136R154R171 prnp allele, wild-type mouse), –; and (v) an experimental bovine isolate of transmissible mink encephalopathy .
Breeds and prnp genotypes of sheep and the survival periods observed after transmission in TgOvPrP4 ovine transgenic mice are shown in Table 1.
Four- to six-week-old female TgOvPrP4 ovine transgenic mice  were inoculated intra-cerebrally with 10% (first passage) or 1% (second passage) (wt/vol) brain homogenates in 5% glucose in distilled water (20 μl per animal). The brains were sampled at the terminal stage of the disease or death of the animal due to intercurrent disease or ageing. The guidelines of the French Ethical Committee (decree 87–848) and European Community Directive 86/609/EEC regarding mice were respected. Experiments were performed in the Biohazard prevention area (A3) of the author’s institution with the approval of the Rhône-Alpes Ethical Committee for Animal Experiments. The whole brain of every second mouse was frozen and stored at −80°C before Western Blot analysis. The other brains were fixed in 10% formol-saline solution for histopathological examinations.
Post-fixed brain were routinely embedded in paraffin after a 1 hour formic acid (98%–100%) treatment. De-waxed and re-hydrated 5 μm brain sections were then either stained using hematoxylin-eosin in order to study vacuolar lesions or immunostained for PrPsc using SAF84 (SPI Bio) and 2G11 (Pourquier) monoclonal antibodies with or without an additional step using streptomycin sulfate, following a procedure reported in detail elsewhere . A peroxydase-labeled avidin-biotin complex (Vectastain Elite ABC, Vector Laboratories) was used to amplify the signal. Final detection was achieved using a solution of diaminobenzidine intensified with nickel chloride (Zymed), producing black deposits. Finally, slides counterstained with aequous hematoxylin were observed under a microscope coupled to an image analysis workstation (Morpho Expert software, ExploraNova). The lesion profiles were built following referential criteria  using a computer-assisted method .
Extraction of PrPres
PrPres was obtained following concentration by ultra-centrifugation from half of the mouse brains homogenised in glucose 5% in distilled water (20% wt/vol). A 600 μl volume was made up to 1.2 ml in glucose 5%, before incubation with proteinase K (10 μg/100 mg brain tissue) (Roche) for 1 h at 37°C. N-lauroyl sarcosyl 30% (600 μl; Sigma) was added. After incubation at room temperature for 15 min, samples were then centrifuged at 100,000 rpm for 2 h on a 400 μl 10% sucrose cushion, in a Beckman TL100 ultracentrifuge. Pellets were resuspended and heated for 5 min at 100°C in 50 μl TD4215 denaturing buffer (SDS 4%, β-mercaptoethanol 2%, glycine 192 mM, Tris 25 mM, sucrose 5%). In some experiments, deglycosylation was performed using PNGase F (kit P07043, BioLabs), as previously described .
Differential immunoprecipitation was used to enrich the samples in the C-terminally cleaved form of PrPres (PrPres #2), by depletion of the usual form of PrPres (PrPres #1).
Superparamagnetic polystyrene beads coated with a monoclonal antibody specific for Fc on all mouse IgG (Dynabeads® Pan Mouse IgG_DYNAL #110.41) were used as recommended by the manufacturer. After each step, the beads were recovered using Dynal PMC. 50 μl bead aliquots were washed 3 times in 5 volumes of coating buffer (PBS with 0.1% of BSA). Beads (50 μl of beads resuspended in 50 μl coating buffer) collected after the last washing were then coated with IgG mouse monoclonal antibodies Sha 31 or SAF84 (ascitic fluids; SPI-Bio, France) for PrPres #1 or PrPres #2 capture, respectively. Sha31 and SAF84 recognise the ovine PrP sequences 148-YEDRYYRE-155 and 167-RPVDQY-172, respectively. For each cycle of PrPres capture, the sample was incubated with antibody-coated beads for 1 h at room temperature under continuous rotation at 60 rpm.
After PrPres ultracentrifugation, the pellets obtained from 2 mg brain tissues were resuspended in 20 μl immunoprecipitation buffer (phosphate-buffered saline [PBS] at pH 7.4 and 0.3% of N-lauroyl sarcosyl) and heated 5 min at 100°C, before addition of a 30 μl suspension of antibody-coated beads. After completing the beads suspension to 1 ml, the sample was enriched in PrPres #2, by depleting the PrPres #1 in 5 to 7 successive rounds of PrPres #1 capture using Sha31-coated beads. The supernatants collected after each capture cycle were used for the next one. PrPres #2 was then captured by SAF84-coated beads. At the end of each capture cycle, PrPres was removed from the beads by heat denaturation for 5 min at 100°C in 30 μl TD4215 buffer prior to Western blot analyses.
Western blot analyses
Western blot analysis was performed as previously described  by 15% SDS-PAGE and electroblotting on nitrocellulose membranes. PrPres was detected with P4 (0.2 μg/ml) (93-WGQGGSH-99 ovine PrPsequence; R-Biopharm, Germany), Bar233 (1/5000) (144-FGNDYEDRYYRE-155 ovine PrP sequence; kindly provided by J. Grassi, C.E.A.-Saclay, France), Sha31 (1/10 from TeSeE Bio-Rad sheep and goats kit; Bio-Rad, France) or SAF84 (SPI-Bio, France) mouse monoclonal antibodies. Peroxidase-labelled conjugate anti-mouse IgG (H+L) (1/2500 in PBST; ref 1010-05; Clinisciences, France) was used to detect P4, Bar233, and Sha31 antibodies, whereas SAF84 was used as horseradish peroxidase antibody. Streptavidin (5 ng/ml) (S5512) was added to the conjugate solution. Bound antibodies were then detected by direct capture with the Versa Doc (Bio-Rad) analysis system using the ECL chemiluminescent substrate (Amersham, France). Quantitative studies were performed using Quantity One (Bio-Rad) software, and the apparent molecular masses were evaluated by comparing the positions of the PrPres bands with a biotinylated marker (B2787) (Sigma, France).
The glycoforms proportions of the four “CH1641-like” isolates and the CH1641 isolate were compared with each other and the glycoforms proportions of both classical BSE and L-type BSE were compared with those of each natural “CH1641-like” isolate and with the experimental CH1641 isolate. Comparison of classical BSE alone with each “CH1641-like” isolate and with CH1641 at first passage implies 5 tests for each of the 3 PrPres #1 bands. In view of the high total number of tests (19 for each PrPres band), paired-sample t tests with Bonferroni adjustment were used to preclude the detection of spurious differences in glycoform proportions.
A classical analysis of variance was used for comparisons of PrPres #2. The statistical analysis was performed with R software (R version 2–6.0 [2007-11-03]: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0; http://www.R-project.org).
Western blot comparisons of PrPres in the brains of TgOvPrP4 mice and sheep or cattle. PrPres from sheep (lanes 1, 5, and 7) or cattle (lane 3) and from TgOvPrP4 mice (lanes 2, 4, 6, and 8) was detected using Bar233 (A) and SAF84 (B) antibodies. TSE sources were CH1641, BSE-L, 06-017 (“CH1641-like”), and BSE-C.
(2341 KB TIF)
Neuropathological features of “CH1641-like” isolates in TgOvPrP4 mice. (A-D) Brain lesion profiles (left panels) and disease-associated prion protein brain mapping (right panels) observed in the brains of TgOvPrP4 mice (n = 3–7) infected at first passage with O104, TR316211, 05-825, or 06-017 isolates. 1. Dorsal medulla nuclei. 2. Cerebellar cortex. 3. Superior colliculus. 4. Hypothalamus. 5. Central thalamus. 6. Hippocampus. 7. Lateral septal nuclei. 8. Cerebral cortex at the level of thalamus. 9. Cerebral cortex at the level of septal nuclei. (E) Immunohistochemical detection of disease-associated prion protein in the brain of TgOvPrP4 mice; signal intensity was different in the cortex between L-type BSE and “CH1641-like” sheep scrapie. In the raphe dorsalis intensity was similar, but the deposition was slightly different and appeared intraneuronal in the case of the “CH1641-like” sheep scrapie group.
(0.88 MB TIF)
We are grateful to Dominique Canal for the Western blot experiments; Céline Raynaud and Mickaël Leboidre for histotechnical assistance; and Emilie Antier, Clément Lavigne, and Latefa Chouaf-Lakhdar for the follow-up of animal experiments.
Conceived and designed the experiments: T. Baron, A-G Biacabe. Performed the experiments: J. Vulin, J. Verchere, D. Betemps. Analyzed the data: T. Baron, A. Bencsik, E. Morignat. Wrote the paper: T. Baron, A. Bencsik.
- 1. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95: 13363–13383.
- 2. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, et al. (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 278: 40429–40436.
- 3. Biacabe A-G, Jacobs JG, Bencsik A, Langeveld JPM, Baron T (2007) H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases. Prion 1: 61–68.
- 4. Baron T, Madec J-Y, Calavas D, Richard Y, Barillet F (2000) Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep. Neurosci Lett 284: 175–178.
- 5. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383: 685–690.
- 6. Eloit M, Adjou K, Coulpier M, Fontaine J-J, Hamel R, et al. (2005) BSE agent signatures in a goat. Vet Rec 156: 523–524.
- 7. Hill AF, Sidle KCL, Joiner S, Keyes P, Martin TC, et al. (1998) Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett 255: 159–162.
- 8. Kuczius T, Haist I, Groschup MH (1998) Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J Infect Dis 178: 693–699.
- 9. Stack J, Chaplin MJ, Clark J (2002) Differentiation of prion protein glycoforms from naturally occuring sheep scrapie sheep-passaged scrapie strains (CH1641 and SSBP1) bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol 104: 279–286.
- 10. Thuring CM, Erkens JHF, Jacobs JG, Bossers JG, van Keulen LJM, et al. (2004) Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size immunoreactivity and glycoprofile of prion protein. J Clin Microbiol 42: 972–980.
- 11. Foster JD, Dickinson AG (1988) The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet Rec 123: 5–8.
- 12. Hope J, Wood SCER, Birkett CR, Choing A, Bruce ME, et al. (1999) Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J Gen Virol 80: 1–4.
- 13. Lezmi S, Martin S, Simon S, Comoy E, Bencsik A, et al. (2004) Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental BSE in sheep using Western blot and immunohistochemical method. J Virol 78: 3654–3662.
- 14. Stack M, Jeffrey M, Gubbins S, Grimmer S, Gonzales L, et al. (2006) Monitoring for bovine spongiform encephalopathy in sheep in Great Britain, 1998–2004. J Gen Virol 87: 2099–2107.
- 15. Fraser H, Bruce ME, Chree A, McConnell I, Wells GA (1992) Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 73: 1891–1897.
- 16. Bruce ME, Boyle A, Cousens S, McConnell I, Foster J, et al. (2002) Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol 83: 695–704.
- 17. Brown DA, Bruce ME, Fraser JR (2003) Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 29: 262–72.
- 18. Lezmi S, Bencsik A, Baron T (2006) PET-blot analysis contributes to BSE strain recognition in C57Bl/6 Mice. J Histochem Cytochem 54: 1087–1094.
- 19. Baron T, Crozet C, Biacabe A-G, Philippe S, Verchère J, et al. (2004) Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice. J Virol 78: 6243–6251.
- 20. Baron T, Biacabe AG (2007) Molecular behaviors of "CH1641-like" sheep scrapie isolates in ovine transgenic mice (TgOvPrP4). J Virol 81: 7230–7237.
- 21. Biacabe AG, Laplanche JL, Ryder S, Baron T (2004) Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 5: 110–115.
- 22. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, et al. (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 101: 3065–3070.
- 23. Buschmann A, Gretzschel A, Biacabe A-G, Schiebel K, Corona C, et al. (2006) Atypical BSE in Germany. Proof of transmissibility and biochemical characterisation. Vet Microbiol 117: 103–116.
- 24. Jacobs JG, Langeveld JPM, Biacabe AG, Acutis P, Polak MP, et al. (2007) Molecular discrimination of atypical bovine spongiform encephalopathies from a wide geographical region in Europe. J Clin Microbiol 45: 1821–1829.
- 25. Baron T, Biacabe A-G, Bencsik A, Langeveld JPM (2006) Transmission of new bovine prion to mice. Emerg Infect Dis 12: 1125–1128.
- 26. Béringue V, Bencsik A, Le Dur A, Reine F, Laï TL, et al. (2006) Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS Pathog 2: 956–963.
- 27. Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, et al. (2007) Conversion of the BASE prion strain into the BSE strain : the origin of BSE? PLoS Pathog 3: 1–8.
- 28. Béringue V, Andréoletti O, Le Dur A, Essalmani R, Vilotte J-L, et al. (2007) A bovine prion acquires an epidemic BSE strain-like phenotype upon interspecies transmission. J Neurosci 27: 6965–6971.
- 29. Baron T, Bencsik A, Biacabe AG, Morignat E, Bessen RA (2007) Phenotypic similarity of transmissible mink encephalopathy in cattle and L-type bovine spongiform encephalopathy in a mouse model. Emerg Infect Dis 13: 1887–1894.
- 30. Jeffrey M, Gonzalez L, Chong A, Foster J, Goldmann W, et al. (2006) Ovine infection with the agents of scrapie (CH1641 isolate) and bovine spongiform encephalopathy: immunochemical similarities can be resolved by immunohistochemistry. J Comp Pathol 134: 17–29.
- 31. Baron TG, Madec JY, Calavas D (1999) Similar signature of the prion protein in natural sheep scrapie and bovine spongiform encephalopathy-linked diseases. J Clin Microbiol 37: 3701–3704.
- 32. Acutis PL, Martucci F, Mazza M, Nodari S, Maurella C, et al. (2006) Molecular typing of transmissible spongiform encephalopathy from Italian disease outbreaks in small ruminants. Vet Rec 159: 746–747.
- 33. Nonno R, Esposito E, Vaccari G, Conte M, Marcon S, et al. (2003) Molecular analysis of cases of Italian sheep scrapie and comparison with cases of bovine spongiform encephalopathy (BSE) and experimental BSE in sheep. J Clin Microbiol 41: 4127–4133.
- 34. Siso S, Doherr MG, Bolteron C, Fatzer R, Zurbriggen A, et al. (2007) Neuropathological and molecular comparison between clinical and asymptomatic bovine spongiform encephalopathy cases. Acta Neuropathol 114: 501–508.
- 35. Baron T, Biacabe AG (2006) Origin of bovine spongiform encephalopathy. Lancet 367: 297–298.
- 36. Konold T, Lee YH, Stack MJ, Horrocks C, Green RB, et al. (2006) Different prion disease phenotypes result from inoculation with two temporally separated sources of sheep scrapie from Great Britain. BMC Vet Res 2: 31.
- 37. Espinosa JC, Andréoletti O, Castilla J, Herva ME, Morales M, et al. (2006) Sheep-passaged BSE agent exhibits altered pathobiological properties in bovine-PrP transgenic mice. J Virol 81: 835–843.
- 38. Baron T, Belli P, Madec JY, Moutou F, Vitaud C, et al. (1997) Spongiform encephalopathy in an imported cheetah in France. Vet Rec 141: 270–271.
- 39. Cordier C, Bencsik A, Philippe S, Bétemps D, Ronzon F, et al. (2006) Transmission and characterization of BSE sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). J Gen Virol 87: 3763–3771.
- 40. Crozet C, Bencsik A, Flamant F, Lezmi S, Samarut J, et al. (2001) Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep 21: 952–956.
- 41. Bencsik A, Baron T (2007) Bovine spongiform encephalopathy agent in a prion protein (PrP) ARR/ARR genotype sheep after peripheral challenge: complete immunohistochemical analysis of disease-associated PrP and transmission studies to ovine transgenic mice. J Infect Dis 195: 989–996.
- 42. Crozet C, Flamant F, Bencsik A, Aubert D, Samarut J, et al. (2001) Efficient transmission of two different sheep scrapie isolates transgenic mice expressing the ovine PrP gene. J Virol 75: 5328–5334.
- 43. Bencsik A, Leclere E, Perron H, Moussa A (2008) New insights into early sequential PrPsc accumulation in scrapie infected mouse brain evidenced by the use of streptomycin sulfate. Histochem Cell Biol 129: 643–650.
- 44. Fraser H, Dickinson AG (1968) The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78: 301–311.
- 45. Bencsik A, Philippe S, Vial L, Calavas D, Baron T (2005) Automatic quantitation of vacuolar lesions in the brain of mice infected with transmissible spongiform encephalopathies. J Virol Methods 124: 197–202.